Ismail Baris Turkbey, M.D.
- Center for Cancer Research
- National Cancer Institute
- Building 10 - Room B3B85
- Bethesda, MD 20892
- 240-760-6112
- turkbeyi@mail.nih.gov
RESEARCH SUMMARY
Dr. Turkbey’s main research interests focus on prostate cancer imaging (multiparametric MRI, PET CT), prostate biopsy techniques, focal therapy for prostate cancer and artificial intelligence (segmentation, decision support systems). Dr. Turkbey is the Head of the Artificial Intelligence Resource (AIR), which makes AI tools available to CCR investigators with the goal of developing better screening and detection methods or predictive markers for patients.
Areas of Expertise
Information for Patients
Learn more about our clinical trials and the highly specialized care teams that lead them.
Ismail Baris Turkbey, M.D.
Clinical Trials
Publications
- Bibliography Link
- View Dr. Turkbey's publications in pubmed
Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2
PI-RADS: Where Next?
Biography
Ismail Baris Turkbey, M.D.
Dr. Turkbey obtained his medical degree from Hacettepe University in Ankara, Turkey in 2003. He completed his residency in Diagnostic and Interventional Radiology at Hacettepe University. He joined Molecular Imaging Branch (MIB), National Cancer Institute, NIH in 2007. His main research areas are imaging of prostate cancer (multiparametric MRI, PET CT), image guided biopsy and treatment techniques (focal therapy, surgery and radiation therapy) for prostate cancer and artificial intelligence. Dr. Turkbey is a member of Prostate Imaging Reporting & Data System (PI-RADS) Steering Committee. He is the Head of the Magnetic Resonance Imaging section in MIB and the Artificial Intelligence Resource in MIB.
Job Vacancies
We have no open positions in our group at this time, please check back later.
To see all available positions at CCR, take a look at our Careers page. You can also subscribe to receive CCR's latest job and training opportunities in your inbox.